-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 13/11/25 )
NAV
₹120.59
Last change
₹0.55 +0.0%
Fund Size (AUM)
8346.49 Cr
Performance
20.31% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 13/11/25
AUM
8346.49 Cr
Expense Ratio
1.82 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | 0.91% | 20.84% | 20.31% |
| BSE Healthcare TR INR | 1.4% | 23.01% | 18.25% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.67% |
Divi's Laboratories Ltd |
8.07% |
Lupin Ltd |
7.26% |
Cipla Ltd |
6.29% |
Apollo Hospitals Enterprise Ltd |
5.97% |
Dr Reddy's Laboratories Ltd |
5.62% |
Vijaya Diagnostic Centre Ltd |
3.42% |
Medplus Health Services Ltd |
3.32% |
Gland Pharma Ltd |
3.05% |
GlaxoSmithKline Pharmaceuticals Ltd |
2.87% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
100%
Equity
-
0%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.66% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.98% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.55% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
19.55% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.65% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
17.65% (5Y)
-
